Speaker: Fredrik Piehl, Professor, Karolinska Institutet
What key insights will you be sharing in your session and why is this important?
Fredrik Piehl: I will talk about infections and MS therapies, which is a growing concern with increasingly effective therapies. However, not all DMTs nor people with MS have the same risk profile, and it's important to be as precise as possible. This will help us to establish a benefit risk profile at the individual level.
Why is ECTRIMS 2024 a must-attend event for the MS and neurological research community?
Fredrik Piehl: I very much look forward to meeting old and new friends and colleagues at ECTRIMS in Copenhagen, the greatest annual event in the MS world for sharing novel insights in all aspects of MS and related disorders.
